Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemolytic uremic syndrome].

S Rota1, P Cravedi, G Remuzzi

  • 1Divisione di Nefrologia, Azienda Ospedaliera, Ospedali Riuniti, Bergamo.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|January 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics of rare diseases of the kidney: learning from mouse models.

Cytogenetic and genome research·2004
Same author

Nephrotoxic aspects of cyclosporine.

Transplantation proceedings·2004
Same author

Proteinuria and its consequences in renal disease.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2004
Same author

Pharmacological and clinical profile of valsartan.

Drugs of today (Barcelona, Spain : 1998)·2004
Same author

[Thrombotic microangiopathy].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2003
Same author

[Mechanisms of endothelial damage in thrombotic microangiopathy].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2003
Same journal

[Rufus of Ephesus, On gout].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

A Case Report and Literature Review: Chlorhexidine-induced anaphylaxis in a hemodialysis patient.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

New Frontiers in the Treatment of Chronic Kidney Disease-associated Pruritus: A Case of Hemoperfusion with HA130.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Fibronectin Glomerulopathy: A Case Report of Membranoproliferative Glomerulonephritis.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Sodium Disorders in Multiple Myeloma: Beyond Pseudohyponatremia to Clinical Pitfalls and Mechanistic Insights.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same journal

Acute Kidney Injury and Early Diagnostic Biomarkers: A Narrative Literature Review.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
See all related articles

Hemolytic uremic syndrome (HUS) is a kidney disease often caused by E. coli. Genetic factors affecting complement regulation are linked to severe non-Shiga toxin-associated HUS, impacting prognosis.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Context:

  • Hemolytic uremic syndrome (HUS) is a triad of non-immune hemolytic anemia, thrombocytopenia, and acute kidney injury.
  • In children, Shiga-like toxin-producing E. coli (Stx-E. coli) is the most common trigger for HUS, with most patients recovering renal function.
  • Non-Shiga toxin-associated HUS (non-Stx-HUS), comprising 5-10% of cases, has a significantly worse prognosis, with high rates of end-stage renal disease (ESRD), neurological damage, and mortality.

Purpose:

  • To explore the genetic underpinnings of non-Shiga toxin-associated Hemolytic Uremic Syndrome (HUS).
  • To investigate the role of complement regulatory protein abnormalities in both familial and sporadic non-Stx-HUS.
  • To highlight the association between mutations in complement genes and the predisposition to severe HUS forms.

Related Experiment Videos

Summary:

  • Genetic studies reveal that familial non-Stx-HUS is linked to abnormalities in complement regulatory proteins, specifically Factor H and MCP.
  • Evidence suggests similar genetic alterations may predispose individuals to sporadic non-Stx-HUS.
  • Mutations in genes for Factor H and MCP are implicated, influencing complement regulation and increasing HUS susceptibility.

Impact:

  • Identifies genetic factors contributing to the poor outcomes observed in non-Stx-HUS.
  • Suggests a potential for genetic screening in at-risk populations for non-Stx-HUS.
  • Advances understanding of complement system dysregulation in HUS pathogenesis.